Morepen Laboratories Ltd. Financials: Quarterly Results
Revenue
487.97
Cr.
PAT
27.50
Cr.
EBITDA
39.74
Cr.
Morepen Laboratories Ltd. Q3FY26 Financial Metrics
| Indicator | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 484.16 | 411.58 | 425.24 | 465.85 | 452.78 |
| Total Income From Operations (Cr.) | 484.16 | 411.58 | 425.24 | 465.85 | 452.78 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 39.74 | 24.05 | 19.55 | 30.39 | 36.55 |
| P/L Before Exceptional Items & Tax (Cr.) | 35.42 | 19.87 | 15.52 | 25.71 | 35.21 |
| P/L After Tax from Ordinary Activities (Cr.) | 27.50 | 41.04 | 11.41 | 20.31 | 26.69 |
| Net Profit/Loss For the Period (Cr.) | 27.50 | 41.04 | 11.41 | 20.31 | 26.69 |
| Basic EPS | 0.50 | 0.75 | 0.20 | 0.35 | 0.49 |
FAQs
Morepen Laboratories Ltd. announced its quarterly results for Q3 FY2026 on February 10, 2026.
In Q3 FY2026, Morepen Laboratories Ltd. are as follows:
Revenue: ₹487.97 crore
Net Profit: ₹27.50 crore.
For Q3 FY2026, Morepen Laboratories Ltd. posted ₹487.97 crore in revenue and ₹27.50 crore in net profit.
Past quarterly results for Morepen Laboratories Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.